Health knowledge made personal
Join this community!
› Share page:
Search posts:

Vitamin C Recovery From Viral Pneumonia in New Zealand Farmer

Posted Sep 21 2010 12:10am

Vitamin C Saves Life of Man Dying of Viral Pneumonia

by Jeffrey Dach MD

The Allan Smith Story a TV Documentary from New Zealand

A New Zealand Dairy farmer named Allan Smith came down with a severe form of Swine Flu progressing rapidly to a comatose condition from extensive pulmonary infection. His chest Xrays showed complete opacification (white out) of the lungs.  Kept alive for three weeks on a ventilator in the ICU, Allan hovered close to death.  Finally, the doctors said it was time to turn off the machines and let him die. The Doctors met with the family, said there was no hope, and asked the family to agree with the decision to turn off life support and let Alan die.  One of the brothers stepped in and said to the doctors, "you haven't tried everything, You have got to try high dose IV vitamin C".  The doctors refused, saying there is no proof that Vitamin C would work. Alan Smith's three sons stepped in and said there was nothing to lose, and presented a persuasive argument to try the IV vitamin C.

Even though all the Doctors were in agreement that Vitamin C would be of no benefit and that Mr Smith would certainly die, one doctor "felt slightly uneasy" with the decision to turn off life support, and so they agreed to try the Vitamin C.  The plan was to give the IV Vitamin C, show it was useless, and then turn off life support.

That day, Allan Smith was given 25 grams of vitamin C IV in the evening and another 25 grams in the morning.  The next day a CAT scan of the lungs showed improvement and the Chest Xrays, which initially showed total opacification (white out), now showed dramatic clearing of the lungs after the IV vitamin C.  However, the doctors attributed the dramatic improvement to "turning patient into a prone position", and not to the IV vitamin C. 

In less than a week after IV vitamin C, Alan could be taken off ECMO life support, and started breathing on his own.  However, unexpectedly, a different physician consultant came in, took over the case and stopped the IV vitamin C.  Alan Smith's condition promptly deteriorated.  Allan's wife, Sonia,  called a meeting with this new doctor to no avail.  In a meeting with Allan's wife Sonia, this  new doctor rolled his eyes and looked up at the ceiling and said "No More Vitamin C ".  Not giving up, the three brothers called a meeting with this new doctor demanding the IV vitamin C.  The three brothers again used their powers of "persuasion", and the doctors reluctantly gave in.  The IV vitamin C was restarted, but only at low doses of one gram a day.  The brothers said, "Mucking about with the Vitamin C showed in his fathers health".  "You had to be thick not to see it."  

Allan Smith continued to recover slowly and was eventually transferred to a hospital closer to home, still breathing with ventilator assistance.  Here, the family had another battle with a yet another new doctor who again stopped the IV Vitamin C.  This time. the family brought in a lawyer, a Wellington Public law specialist who sent a warning letter to the hospital threatening legal action.  The hospital was forced to restart the vitamin C, yet allowed only the low dosage.  Finally, Allan Smith was able to sit up in bed and take liquids.   The family then switched Allan to oral vitamin C  ( Lypo-spheric C from LivOn Labs ) at a dosage of 6 grams a day.  Allan finally was discharged home from the hospital.  At home, Allan's neighbor John joked with him, and said, "Allan, you owe me the 15 dollars I paid to have my suit dry cleaned for your funeral. and you bugger, you came back."

Watch Allan Smith's Recovery from Swine Flu Pneumonia New Zealand TV.

video part one

Part Two

Part Three of Documentary

Follow up segment on vitamin C- new zealand.  Stories of patients and families battled with hospital over using vitamin c.

Click Here to Watch Video of part three. Interviewed in part three was the Principle Advisor to the Health Ministry and Senior Intensive Care Specialist, David Galler  who denied that the intravenous Vitamin C was a contributing factor in the Allan Smith's recovery.  He proclaimed that the recovery could have been just as likely from a "bus driving by" as the high dose Vitamin C .  When asked what he would need as proof to that Vitamin C is effective,  he replied he would need a full scale clinical trial funded by a pharmaceutical company.

We all know this could never happen as pharmaceutical companies will never fund studies on non-patentable natural substance.  There is no profit in it.  Dr David Galler and his colleagues refuse to look at the accumulated overwhelming evidence of the safety and efficacy of vitamin C over the past 75 years.

part 4 of Documentary

Click  Here   to see part Four

This is a Video interview of Dr Thomas Levy on Campbell Live TV Show says that that he was not surprised at the miraculous outcome, and there is no doubt that Vitamin C saved Allan Smith's life.  Dr Levy sees these types of results regularly from IV Vitamin C and he expects them.

Transcript of Interview
TV Journalist to Dr Levy: 
  Why do you believe in Vitamin C?

Dr Levy: This is not a belief like its a religion.  Data has accumulated over the past 75 years. 
Studies are published at Harvard and New England Journal.  Its amazing that a result is published in a journal and still doesn't make its way into practice

Experts say we don't see the proof this is efficacious.

Vitamin C by injection is a registered medicine for treatment of vitamin C deficiency in Zealand.
Vitamin C is registered for IV injection.

Where is the evidence it is the kind of cure you say it is?

I wrote a book , Curing the incurable with 1200 references in the medical literature over the past 85 years , Vitamin C is enormously effective in eradicating infection and toxins.

Experts say we cannot recommend it.  We can find no evidence? Why is this?

I would have to now the motivation because this information s readily available.  Its not information that is hidden,  its readily available. I would suggest they are closed minded.

I know for a fact by personally using Vitamin C  and giving it to my patients and hundred of other doctors . What you saw that happened to Allan Smith happens on a regular basis.

How do you know it was vitamin C?  Are you singing for your supper? You passionately believe this works.

I passionately know it works.  This is not something I have any uncertainly about.  If someone treats a dozen patients with pneumococcal pneumonia and they recover, it is the same thing.  I've seen and done the same thing with Vitamin C.


Virus Pneumonia and Its Treatment With Vitamin C . Fred R. Klenner, M.D., Reidsville, North Carolina
Read by Title to the Tri-State Medical Association of the Carolinas and Virginia, meeting at Charleston, February 9th and 10th
South Med Surg. 1949 Jul;111(7):209-14.
The treatment of poliomyelitis and other virus diseases with vitamin C. KLENNER FR.
Clinical Guide to the Use of Vitamin C The Clinical Experiences of Frederick R. Klenner, M.D.,
abbreviated, sumarized and annotated by Lendon H. Smith, M.D.
2233 SW Market Street, Portland, Oregon 97201
ASCORBIC ACID AS A CHEMOTHERAPEUTIC AGENT  W. J. McCoRmicx, M.D.,Toronto, Canada. ARCHIVES OF PEDIATRICS, New York The Practical Monthly on the Diseases of Infants and Children 69: 151-155, April 1952
The Origin of the 42-Year Stonewall of Vitamin C Robert Landwehr1
Vitamin C: Intravenous Use by Complementary and Alternative Medicine Practitioners and Adverse Effects Sebastian J. Padayatty1., Andrew Y. Sun1., Qi Chen2, Michael Graham Espey1, Jeanne Drisko2, Mark Levine1* 1 Molecular and Clinical Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America, 2 Program in Integrative Medicine, University of Kansas Medical Center, Kansas City, Kansas, United States of America
Injectable Vitamin C, an e-book on the internet by Robert McCracken PhD
Cochrane Database Syst Rev. 2007 Jan 24;(1):CD005532.
Vitamin C for preventing and treating pneumonia.Hemilä H, Louhiala P.
University of Helsinki, Department of Public Health, POB 41, Mannerheimintie 172, Helsinki, Finland, FIN-00014.

AUTHORS' CONCLUSIONS: The prophylactic use of vitamin C to prevent pneumonia should be further investigated in populations who have high incidence of pneumonia, especially if dietary vitamin C intake is low. Similarly, the therapeutic effects of vitamin C should be studied especially in patients with low plasma vitamin C levels. The current evidence is too weak to advocate widespread prophylactic use of vitamin C to prevent pneumonia in the general population. However, therapeutic vitamin C supplementation may be reasonable for pneumonia patients who have low vitamin C plasma levels because its cost and risks are low.

Low Vitamin C levels in Hospitalized patients
Nutrition. 2009 Dec 15. [Epub ahead of print]
Metabolic origin of hypovitaminosis C in acutely hospitalized patients. Evans-Olders R, Eintracht S, John Hoffer L.
Lady Davis Institute for Medical Research, McGill University and Jewish General Hospital, Montreal, Quebec, Canada.

RESULTS: Vitamin C administration increased plasma and mononuclear leukocyte vitamin C concentrations from subnormal (16.3 +/- 12.4 mumol/L and 6.5 +/- 5.5 mmol/L, respectively) to normal (71.0 +/- 30.9 mumol/L, P < 0.0001, and 8.2 +/- 6.8 mmol/L, P < 0.015); the mood disturbance score improved by 33% (P < 0.008). There was no increase in plasma glutathione concentrations or a reduction in plasma or mononuclear leukocyte malondialdehyde concentrations. An inverse relation was observed between plasma C-reactive protein and plasma vitamin C concentrations (P = 0.006).
Eur J Intern Med. 2003 Nov;14(7):419-425. Hypovitaminosis C in hospitalized patients.
Fain O, Pariés J, Jacquart B, Le Moël G, Kettaneh A, Stirnemann J, Héron C, Sitbon M, Taleb C, Letellier E, Bétari B, Gattegno L, Thomas M.

RESULTS: The prevalence of hypovitaminosis C (depletion: SAAL<5 mg/l or deficiency: SAAL<2 mg/l ) was 47.3%. Some 16.9% of the patients had vitamin C deficiency. There was a strong association between hypovitaminosis C and the presence of an acute phase response (p=0.002). Other univariate risk factors for vitamin C depletion were male sex (p=0.02), being retired (p=0.037), and infectious diseases (p=0.002). For vitamin C deficiency, the significant univariate risk factors included the same ones found for vitamin C depletion, plus being unemployed (p=0.003) and concomitant excessive alcohol and tobacco consumption (p<0.0001). Logistic regression showed that being retired (p=0.015) and concomitant excessive alcohol and tobacco consumption (p=0.0003) were significant independent risk factors. Hemorrhagic syndrome and edema were described more often in patients with vitamin C deficiency than in those with vitamin C depletion or without hypovitaminosis. Clinical signs were more frequent for an ascorbic acid level below 2.5 mg/l.

CONCLUSION: Hypovitaminosis C is frequent in hospitalized patients but should be interpreted according to the presence or absence of an acute phase response. The main risk factors are living conditions and excessive alcohol and tobacco consumption.
Journal of the American College of Nutrition, Vol. 27, No. 3, 428-433 (2008)
Published by the American College of Nutrition  Vitamin C Deficiency in a University Teaching Hospital
Runye Gan, Shaun Eintracht, MD and L. John Hoffer, MD, PhD

ICU Study on ventilator dependency
Injury. 2010 Jul;41(7):857-61. Epub 2010 Feb 10.

High-dose antioxidant administration is associated with a reduction in post-injury complications in critically ill trauma patients. Giladi AM, Dossett LA, Fleming SB, Abumrad NN, Cotton BA.  Department of Surgery, University of Michigan, Ann Arbor, MI, United States.  Abstract BACKGROUND: We recently demonstrated a high-dose antioxidant (AO) protocol was associated with reduction in mortality. The purpose of this study was to evaluate the impact of AO on organ dysfunction and infectious complications following injury.

PATIENTS AND METHODS: High-dose AO protocol: ascorbic acid 1000 mg q 8 h, alpha-tocopherol 1000 IU q 8 h, and selenium 200 mcg qd for 7-day course. Retrospective cohort study evaluating all patients admitted after protocol implementation (AO+), October 1, 2005 to September 30, 2006. Comparison cohort (AO-): all patients admitted in the year prior to implementation, October 1, 2004 to September 30, 2005.

RESULTS: 2272 patients included in the AO+ group, 2022 patients in the AO- group. Demographics and injury severity were similar. Abdominal compartment syndrome (ACS) (2.9% vs. 0.7%, <0.001), surgical site infections (2.7% vs. 1.3%, p=0.002), pulmonary failure (27.6% vs. 17.4%, p<0.001), and ventilator-dependent respiratory failure (10.8% vs. 7.1%, p<0.001) were significantly less in the AO+ group. Multivariate regression showed 53% odds reduction in abdominal wall complications and 38% odds reduction in respiratory failure in the AO+ group.

CONCLUSIONS: Implementation of a high-dose AO protocol was associated with a reduction in respiratory failure and ventilator-dependence. In addition, AO were associated with a marked decrease in abdominal wall complications, including ACS and surgical site infections.

Vitamin C Prevents Flu
Exp. Biol. Med. 2007;232:847-851   Ascorbic Acid Role in Containment of the World Avian Flu Pandemic
John T. A. Ely1  Radiation Studies, University of Washington, Seattle, Washington 98195

 (i) ascorbic acid is not being administered to humans infected or at risk for influenza, and (ii) ascorbic acid is (mistakenly) believed to be a vitamin ("vitamin C"). Proper use of ascorbic acid as described here could provide effective containment for the flu pandemic.

animal studies
2006 American Society for Nutrition J. Nutr. 136:2611-2616, October 2006
Nutritional Immunology-
Vitamin C Deficiency Increases the Lung Pathology of Influenza Virus–Infected Gulo–/– Mice1
Wei Li2, Nobuyo Maeda3 and Melinda A. Beck2,*
2 Departments of Nutrition, and 3 Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599

We conclude that vitamin C is an important nutrient for adequate immune function and limitation of pathogenesis following influenza virus infection.

In response to the Auckland DHB 14th September press release, visiting Vitamin C expert, Dr Thomas Levy said today, “to assert that there is ‘no evidence’ that high-dose vitamin C is either safe or effective is to ignore the results of thousands of such IV administrations by doctors around the world, as well as to ignore tens of thousands of articles in the medical literature, in the most esteemed medical institutions in the world, that have been published over the last 70 years.” The DHB decision was made in the wake of mounting demand for high-dose vitamin C after news broke out of Waikato Dairy farmer Alan Smith’s complete recovery from what the hospital classed as a terminal case of Swine flu. Mr Smith is the hospital’s only Swine Flu patient on life support to have survived. He is also the only one to have received the high-dose intravenous vitamin C, which was administered at the family’s request after being advise that life support, and therefore his life, were about to be terminated.

Introduced by Alan Smith himself, Dr Levy, cardiologist, associate professor, lawyer and author, spoke about Vitamin C, use, myths, safety and efficacy on Friday 17th September, at Auckland Girls Grammar School, New Zealand.

Thomas Levy MD JD Book Curing the Incurable
Curing the Incurable, Vitamin C, Infectious Disease and Toxins by Thomas E Levy MD JD 
 A Remarkable Medicine Has Been Overlooked, December 15, 2007 By  Jeffrey Dach MD
Lypo-SphericTM Vitamin C proven many times more powerful than all other oral forms of Vitamin C
Recent clinical trials by world-renowned Vitamin C expert and pharmacologist, Steve Hickey, PhD, show that Lypo-SphericTM Vitamin C is able to produce serum levels of Vitamin C nearly double those thought theoretically possible with any oral form of Vitamin C.*

LivOn Laboratories
2654 W. Horizon Ridge Pkwy,
Suite B5-108
Henderson, NV 89052
Combined Impact of Health Behaviours and Mortality in Men and Women: The EPIC-Norfolk Prospective Population Study  Kay-Tee Khaw1*, Nicholas Wareham2, Sheila Bingham3, Ailsa Welch1, Robert Luben1, Nicholas Day1

population study of 20,244 men and women with no known cardiovascular disease or cancer
at baseline survey in 1993–1997, living in the general community in the United Kingdom,
and followed up to 2006. Participants scored one point for each health behaviour: current
 non-smoking, not physically inactive, moderate alcohol intake (1–14 units a week)
and plasma vitamin C >50 mmol/l
indicating fruit and vegetable intake of at least five servings a day, for a total score ranging from zero to four.
Lancet. 2001 Mar 3;357(9257):657-63.

Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition.
Khaw KT, Bingham S, Welch A, Luben R, Wareham N, Oakes S, Day N.
Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge School of Clinical Medicine, UK.    lasma ascorbic acid concentration was inversely related to mortality from all-causes, and from cardiovascular disease, and ischaemic heart disease in men and women. Risk of mortality in the top ascorbic acid quintile was about half the risk in the lowest quintile (p<0.0001).
American Journal of Clinical Nutrition, Vol. 87, No. 1, 64-69, January 2008
Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer–Norfolk prospective population study 1,2,3
Phyo K Myint, Robert N Luben, Ailsa A Welch, Sheila A Bingham, Nicholas J Wareham and Kay-Tee Khaw

top quartiles of baseline plasma vitamin C concentrations had a 42% lower risk (relative risk: 0.58; 95% CI: 0.43, 0.78) than did those in the bottom quartile,
Int J Tuberc Lung Dis. 1999 Sep;3(9):756-61.

Vitamin C and acute respiratory infections. Hemilä H, Douglas RM. Department of Public Health, University of Helsinki, Finland.
So far over 60 studies have examined the effects of vitamin C on the common cold. No effect on common cold incidence was observed in the six largest studies, indicating that vitamin C has no preventive effects in normally nourished subjects in the Western countries. There are, however, smaller studies reporting benefit. In three trials of subjects under heavy acute physical stress, common cold incidence decreased by on average 50%, and in four trials of British males common cold incidence decreased by on average 30% in the vitamin C groups. The dietary vitamin C intake in the UK is low, and consequently the benefit may be due to the correction of marginal deficiency, rather than high vitamin doses. Regular vitamin C supplementation (> or =1 g/day) has quite consistently reduced the duration of colds, but the size of the benefit has varied greatly. In the four largest studies the duration of colds was reduced only by 5%. In two of these studies, however, absence from school and work was reduced by 14-21% per episode, which may have practical importance. Three controlled studies recorded a reduction of at least 80% in the incidence of pneumonia in the vitamin C group, and one randomised trial reported substantial treatment benefit from vitamin C in elderly UK patients hospitalized with pneumonia or bronchitis. It seems that the preventive effects of supplementation are mainly limited to subjects with low dietary vitamin C intake, but therapeutic effects may occur in wider population groups. Further carefully designed trials are needed to explore the effects of vitamin C.
The effectiveness of vitamin C in preventing and relieving the symptoms of virus-induced respiratory infections.  Gorton HC, Jarvis K. Abstract

BACKGROUND: An ever increasing demand to evaluate the effect of dietary supplements on specific health conditions by use of a "significant scientific" standard has prompted the publication of this study.

OBJECTIVE: To study the effect of megadose Vitamin C in preventing and relieving cold and flu symptoms in a test group compared with a control group.

DESIGN: Prospective, controlled study of students in a technical training facility.

SUBJECTS: A total of 463 students ranging in age from 18 to 32 years made up the control group. A total of 252 students ranging in age from 18 to 30 years made up the experimental or test group.

METHOD: Investigators tracked the number of reports of cold and flu symptoms among the 1991 test population of the facility compared with the reports of like symptoms among the 1990 control population. Those in the control population reporting symptoms were treated with pain relievers and decongestants, whereas those in the test population reporting symptoms were treated with hourly doses of 1000 mg of Vitamin C for the first 6 hours and then 3 times daily thereafter. Those not reporting symptoms in the test group were also administered 1000-mg doses 3 times daily.

RESULTS: Overall, reported flu and cold symptoms in the test group decreased 85% compared with the control group after the administration of megadose Vitamin C.

CONCLUSION: Vitamin C in megadoses administered before or after the appearance of cold and flu symptoms relieved and prevented the symptoms in the test population compared with the control group.

Jeffrey Dach MD
4700 Sheridan Suite T
Hollywood Fl 33021

Disclaimer click here:

The reader is advised to discuss the comments on these pages with his/her personal physicians and to only act upon the advice of his/her personal physician. Also note that concerning an answer which appears as an electronically posted question, I am NOT creating a physician -- patient relationship. Although identities will remain confidential as much as possible, as I can not control the media, I can not take responsibility for any breaches of confidentiality that may occur.

Link to this article
Copyright (c) 2010,11 Jeffrey Dach MD All Rights Reserved. This article may be reproduced on the internet without permission, provided there is a link to this page and proper credit is given.

FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of issues of significance. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

Post a comment
Write a comment:

Related Searches